1 not yet recruiting. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Not yet recruiting 1 |
| Phase 3 | 1 | Not yet recruiting 1 |
Follow Progressive Multifocal Leukoencephalopathy: new trials by email Literature Review of Progressive Multifocal Leukoencephalopathy trials Research Report on Progressive Multifocal Leukoencephalopathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pembrolizumab in Progressive Multifocal Leukoencephalopathy (PML) in Immunocompromised Patients Without HIV Infection Pembrolizumab, 25 mg/ml solution for intravenous (IV) injection - Progressive Multifocal Leukoencephalopathy | Phase 2 / Phase 3 | Not yet recruiting | Assistance Publique - Hôpitaux de Paris | 33 | 2024-04-01 | 2024-02-26 |
Leukoencephalopathy, Progressive Multifocal (1)
Brain Diseases (1) · Central Nervous System Diseases (1) · Central Nervous System Infections (1) · Central Nervous System Viral Diseases (1) · DNA Virus Infections (1) · Demyelinating Diseases (1) · Encephalitis (1) · Encephalitis, Viral (1) · Infections (1) · Infectious Encephalitis (1) · Leukoencephalopathies (1) · Nervous System Diseases (1) · Neuroinflammatory Diseases (1) · Polyomavirus Infections (1) · Slow Virus Diseases (1)
Injections (1) · Solutions (1) · pembrolizumab (1)
Assistance Publique - Hôpitaux de Paris (1)
France (1)
2023 (1)